Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possibile prognostic significance on tumor progression

In Vivo

Volumn 24, Issue 2, 2010, Pages 239-241

  Brivio, Fernando ^a   Fumagalli, Luca ^a   Fumagalli, Gabriele ^b   Pescia, Simonetta ^b   Brivio, Rinaldo ^b   Di Fede, Giuseppe ^c   Rovelli, Franco ^b   Lissoni, Paolo ^c  

^a Bassini Hospital   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c Institute of Biological Medicine   (Italy)

Author keywords

Chronobiology; Cortisol rhythm; Melatonin; Pineal gland; Synchronization

Indexed keywords

HYDROCORTISONE; MELATONIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BEDTIME DOSAGE; BONE METASTASIS; CANCER PATIENT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; PANCREAS ADENOCARCINOMA; PERITONEUM METASTASIS; PROGNOSIS; PROSTATE CANCER; SOLID TUMOR; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR GROWTH;

EID: 77950612257     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mormont MC and Levi F: Circadian system alterations during cancer progression: a review. Int J C The pineal gland and cancer 70: 241-247, 1997. (Pubitemid 27107423)
2. Touitou Y, Bogadan A, Levi F, Benavides M and Auzeby A: Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens. Br J Cancer 74: 1248-1252, 1996. (Pubitemid 26360114)
3. Van der Pompe G, Antoni MH and Heijnen CJ: Elevated basal cortisol levels and attenuated ACTH and cortisol response to a behavioural challenge in women with metastatic breast cancer. Psychoneuroendocrinology 21: 361-374, 1996.
4. Sephton SE, Sapolsky RM, Kraemer HC and Spiegel D: Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92: 994-1000, 2000.
5. Lissoni P, Brivio F, Fumagalli L, Messina G, Secreto G, Romelli B, Fumagalli G, Rovelli F, Colciago M and Brera G: Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia. In Vivo 21(4): 647-650, 2007. (Pubitemid 47232666)
6. McEwen BS, Biron CA, Brunson KW, Bulloch K, Chanbers WH, Dhabhar FS, Goldfarb RH, Kitson RP, Miller AH, Spencer RL and Wiess JM: The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Rev 23: 79-133, 1997.
7. Antoni MH: Psychoneuroimmunology of cancer. Brain Behav Immun 17: 84-91, 2003.
8. Lissoni P, Messina G, Parolini D, Balestra A, Brivio F, Fumagalli L, Vigoré L and Rovelli F: A spiritual approach in the treatment of cancer: relation between faith score and response to chemotherapy in advanced non-small cell lung cancer patients. In Vivo 22: 577-582, 2008.
9. Mazzoccoli G, Carughi S, De Cata A, La Viola M and Vendemiale G: Melatonin and cortisol serum levels in lung cancer patients at different stages of disease. Med Sci Monit 6: 11-13, 2005.
10. Maestroni GJM: The immunoneuroendocrine role of melatonin. J Pineal Res 14: 1-10, 1993.
11. Brzezinski A: Melatonin in humans. N Engl J Med 336: 186-195, 1997.
12. Bartsch C, Bartsch H and Lippert TH: The pineal gland and cancer: facts, hypotheses and perspectives. Cancer J 5: 194-199, 1992.
13. Otalora BB, Madrid JA, Alvarez N, Vicente V and Rol MA: Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice. J Pineal Res 44: 307-315, 2008.
14. Conti A and Maestroni GJM: The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 19: 103-110, 2001.
15. Lissoni P: Is there a role for melatonin in supportive care? Supp Care Cancer 10: 110-116, 2002.